drugset / Trial / NCT02185066
Phase 1 Study to Compare the Safety, Pharmacokinetic Profiles of CJ-30056 and Lipitor/Glucophage XR
RandomizedCrossoverOpen-labelTreatment
Summary
This study is designed to evaluate safety and pharmacokinetic properties of the two treatments, the administration of CJ-30056 and the co-administration of atorvastatin and metformin XR, in healthy volunteers.
Timeline
- Start
- 2014-07
- Primary completion
- 2014-09
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | Oral |
| Subject | CJ-30056 | Unknown | — | Oral |
| Subject | Metformin | Small molecule | 500 mg | Oral |
Indications
No indication recorded.